300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Financial Services
Construction
Oil and Gas
Mobile
Retail
Payments
Film
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Social Network
B2B
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Facebook
Renewable Energy
Software
Blockchain
Theatre
Medical
Beauty
Web3
Recruiting
Celebrity
Cannabis
Fashion
LGBT
Climate
Food and Beverage
Infrastructure
Life Science
Publishing
Wine and Spirits
Social
Mobile Apps
Real Estate
Finance
Sporting Goods
Music
Manufacturing
Art
Social Media
Franchise
FinTech
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Enterprise
Biotech
Sustainability
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Burkina Faso
Africa
LATAM
Oman
Puerto Rico
Poland
Guernsey
Cameroon
Armenia
Colombia
China
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
New Zealand
Seychelles
Moldova
Paraguay
Botswana
France
South Africa
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Canada
Germany
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Middle East
Indonesia
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Noble Resources, VC Fund

Noble Resources

VC Fund

Wan Chai, Hong Kong

Noble Resources is a VC fund in Wan Chai focused on Medical and Health Care. Noble Group is a global supply chain manager of energy, power & gas products, metals and carbon steel materials, with interests in key facilities that add value at various stages of its supply chains. Noble Group manages a diversified portfolio of essential natural resources, with integrated sourcing, marketing, processing, financing andtransportation operations. Noble Group's Energy segment encompasses a portfolio of oil liquids and coal products and continues to be a significant driver for the Group’s growth. Gas & Power segment includes their retail energy business Noble Americas Energy Solutions and Gas & Power wholesale operations. In Metals & Mining, Noble Group is one of the world’s leading suppliers with interests in iron ore, aluminium, special ores and alloys across key global locations. The Corporate segment incorporates the Logistics business as well as investments in their major associates. Noble Group (SGX: N21) manages a portfolio of global supply chains covering a range of industrial and energy products. Operating from over 60 locations, Noble facilitates the marketing, processing, financing and transportation of essential raw materials. Sourcing bulk commodities from low cost regions such as South America, South Africa, Australia and Indonesia, the Group supplies high growth demand markets, particularly in Asia and the Middle East. Noble Group is ranked number 77 in the 2015 Fortune Global 500. Noble moves essential resources from producers to consumer across the world. Noble Group's success relies on a rigorously managed balance sheet, effective partnerships and a deep understanding of customer needs. Noble’s core strategy is to be the best company in the world at moving the physical commodity from the producer to the consumer and managing the market, credit and operational risk associated with that. Noble Group's solid financial position comes from a rigorously managed balance sheet with exceptional liquidity and a carefully guided exposure to risk - underpinned by deep relationships with global capital providers. At Noble, they have forged some of the most productive and enterprising partnerships in the industry and they have always believed that as their partners grow, so do they. Noble Group put energy and focus into staying relevant and being valuable to their customers, keeping their interests firmly integrated into their DNA.

Total investments:
2
Last investment:
Lead investor:
0%

Last updated:

Industries Noble Resources invests in

MedicalHealth CareGeneticsLife ScienceBiotechnology

Stages Noble Resources invests in

Funding Round

Countries Noble Resources invests in

DenmarkUnited Kingdom

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Medical 2 (100%)
  • Health Care 2 (100%)
  • Genetics 1 (50%)
  • Life Science 1 (50%)
  • Biotechnology 1 (50%)
See all 7 industries →

Country

  • Denmark 1 (50%)
  • United Kingdom 1 (50%)

Team

NameTitleInvestmentsLinksEmail
Jacques Erni
Jacques Erni Group Chief Financial Officer
Group Chief Financial Officer Total investments: 0 Find email

Investments

CompanyDescriptionRoundLinks
Digital Healthcare is a health care company. The company has been acquired by EMIS Group. $3.4M / Dec 09, 2008
Exiqon operates in two business areas: Life Sciences and Diagnostics. Exiqon Life Sciences, a leading provider of flexible solutions for RNA analysis. Exiqon’s research products are used by academia, biotech and pharmaceutical companies around the world to make groundbreaking discoveries about the correlation between gene activity and thedevelopment of cancer and other diseases. Exiqon Diagnostics collaborates with pharmaceutical and diagnostic companies to develop novel molecular diagnostic tests for early detection of diseases which can help physicians make treatment decisions based on the tools developed by Exiqon Life Sciences. $20M / Jun 03, 2005

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Financial Services
Construction
Oil and Gas
Mobile
Retail
Payments
Film
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Social Network
B2B
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Facebook
Renewable Energy
Software
Blockchain
Theatre
Medical
Beauty
Web3
Recruiting
Celebrity
Cannabis
Fashion
LGBT
Climate
Food and Beverage
Infrastructure
Life Science
Publishing
Wine and Spirits
Social
Mobile Apps
Real Estate
Finance
Sporting Goods
Music
Manufacturing
Art
Social Media
Franchise
FinTech
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Enterprise
Biotech
Sustainability
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Burkina Faso
Africa
LATAM
Oman
Puerto Rico
Poland
Guernsey
Cameroon
Armenia
Colombia
China
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
New Zealand
Seychelles
Moldova
Paraguay
Botswana
France
South Africa
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Canada
Germany
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Middle East
Indonesia
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Noble Resources invest in?

Noble Resources invests primarily in Medical, Health Care and Genetics startups, most often at Funding Round stage. Most of the 2 investments tracked by Shizune back companies in Denmark. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Noble Resources?

Public channels for Noble Resources include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Noble Resources?

The team at Noble Resources includes Jacques Erni (Group Chief Financial Officer). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Noble Resources Noble Resources Find emails